Additionally, treatment with oleic acid increased p38 phosphorylation, and blocking p38 prevented AQP9 upregulation, suggesting that AQP9 contributes to oleic acid-induced hepatic steatosis in HepG2 cells through p38 signaling [114]. The gene discussed is AQP9; the disease is fatty liver disease.